Lynze Mitchell
Las Vegas, NV *****
***************@*****.***
Professional Summary
Accomplished Utilization Review Specialist and Quality Assurance Specialist with 5+ years of experience in healthcare and life sciences. Proven expertise in compliance management and quality assurance, leading teams to develop effective testing strategies. Skilled in utilization review processes and maintaining adherence to industry standards. Holds certifications in Blood Pathogens and HIPAA, ensuring a thorough understanding of regulatory requirements. Work Experience
Utilization Review Specialist
EyeMed Vision Care-Mason, OH
March 2023 to January 2025
• Collaborated with healthcare providers and insurance companies to gather necessary information for review process
• Ensured compliance with applicable laws, regulations, accreditation standards, and contractual requirements related to utilization management practices Quality Assurance Specialist/ Workforce Lead
Eversana Life Science Services-Cincinnati, OH
November 2019 to February 2023
• Led a team of 6 quality assurance specialists in the development and execution of comprehensive testing strategies to ensure product quality and compliance with industry standards
• Participated in code reviews to identify potential areas of improvement in terms of code quality and adherence to coding standards
• Supported the compliance team by maintaining and organizing confidential files, documents, and records
• Managed the scheduling and coordination of meetings, trainings, and conferences related to compliance matters
Education
Associate in Science in Health Administration Services Colorado Technical University-Online - Remote
August 2020 to February 2023
Graduate
High School
School for the Creative and Performing Arts - Cincinnati, OH August 1990 to June 1994
Graduate
Skills
• Utilization review
• Customer service (10+ years)
• Medical terminology
Certifications and Licenses
Bloodborne Pathogen
February 2025 to February 2026
Issued by the National Health and Safety Association following OSHA Bloodborne Pathogens Standard 29 CFR 1901.1030
HIPPA
February 2025 to February 2026
Issued by North American Learning Institute